Shares of Sage Therapeutics Inc. (NASDAQ:SAGE), a specialist in rare central nervous system disorders, climbed 67 percent Friday as the Cambridge, Mass.-based company raised $90 million in an initial public offering (IPO) by selling 5 million shares at $18 each, before overallotments.